Skye Bioscience Inc (SKYE)

Apr 02, 2025

Charles Schwab Investment Management Inc. Has $176,000 Position in Skye Bioscience, Inc. (NASDAQ:SKYE) - Defense World

Apr 02, 2025

Apr 02, 2025

Charles Schwab Investment Management Inc. Grows Stock Position in Skye Bioscience, Inc. (NASDAQ:SKYE) - Defense World

Apr 02, 2025

Apr 02, 2025

10,142 Shares in Skye Bioscience, Inc. (NASDAQ:SKYE) Acquired by Virtu Financial LLC - Defense World

Apr 02, 2025

Apr 02, 2025

Virtu Financial LLC Invests $29,000 in Skye Bioscience, Inc. (NASDAQ:SKYE) - Defense World

Apr 02, 2025

Mar 30, 2025

Skye Bioscience, Inc. (NASDAQ:SKYE) Receives Consensus Rating of “Buy” from Analysts - Defense World

Mar 30, 2025

Mar 30, 2025

Skye Bioscience, Inc. (NASDAQ:SKYE) Receives $18.00 Average Price Target from Analysts - Defense World

Mar 30, 2025

Mar 28, 2025

Skye Bioscience, Inc. (NASDAQ:SKYE) Given Consensus Recommendation of "Buy" by Analysts - MarketBeat

Mar 28, 2025

Mar 25, 2025

Skye Bioscience, Inc. (PNK:SKYE) Q4 2024 Earnings Call Transcript - MSN

Mar 25, 2025

Mar 25, 2025

Skye Bioscience (NASDAQ:SKYE) Receives Outperform Rating from William Blair - MarketBeat

Mar 25, 2025

Mar 25, 2025

Skye Bioscience promotes Tu Diep to COO post - The Pharma Letter

Mar 25, 2025

Mar 25, 2025

Craig Hallum Issues Pessimistic Forecast for Skye Bioscience (NASDAQ:SKYE) Stock Price - MarketBeat

Mar 25, 2025

Mar 24, 2025

Skye Bioscience (NASDAQ:SKYE) Announces Quarterly Earnings Results - MarketBeat

Mar 24, 2025

Mar 23, 2025

Skye Bioscience’s SWOT analysis: novel obesity drug stock faces pivotal year - Investing.com Canada

Mar 23, 2025

Mar 23, 2025

Craig Hallum Cuts Skye Bioscience (NASDAQ:SKYE) Price Target to $14.00 - Defense World

Mar 23, 2025

Mar 23, 2025

Skye Bioscience’s (SKYE) “Outperform” Rating Reiterated at William Blair - Defense World

Mar 23, 2025

Mar 22, 2025

Skye Bioscience’s SWOT analysis: novel obesity drug stock faces pivotal year By Investing.com - Investing.com South Africa

Mar 22, 2025

Mar 22, 2025

SKYE Stock Price and Chart — NASDAQ:SKYE - TradingView

Mar 22, 2025

Mar 21, 2025

Skye Bioscience’s Positive Earnings Call Highlights Nimacimab Progress - TipRanks

Mar 21, 2025

Mar 21, 2025

Analysts Offer Insights on Healthcare Companies: Vor Biopharma (VOR), Skye Bioscience (SKYE) and Bristol-Myers Squibb (BMY) - The Globe and Mail

Mar 21, 2025

Mar 21, 2025

Citizens JMP reiterates Skye Bioscience at market outperform By Investing.com - Investing.com Canada

Mar 21, 2025

Mar 21, 2025

Citizens JMP reiterates Skye Bioscience at market outperform - Investing.com India

Mar 21, 2025

Mar 21, 2025

Skye Bioscience (NASDAQ:SKYE) Shares Down 31% – Time to Sell? - Defense World

Mar 21, 2025

Mar 21, 2025

Skye Bioscience (NASDAQ:SKYE) Stock Price Down 31% – Time to Sell? - Defense World

Mar 21, 2025

Mar 21, 2025

Skye Bioscience Reports 2024 Financial Results and Trial Progress - TipRanks

Mar 21, 2025

Mar 20, 2025

Skye Bioscience accelerates nimacimab clinical trial timeline with early enrollment and extended treatment period - MSN

Mar 20, 2025

Mar 20, 2025

Earnings call transcript: Skye Bioscience Q4 2024 highlights financials, product progress - Investing.com

Mar 20, 2025

Mar 20, 2025

Skye Bioscience Inc. (SKYE) reports earnings - Quartz

Mar 20, 2025

Mar 20, 2025

Skye Bioscience Inc reports results for the quarter ended December 31Earnings Summary - TradingView

Mar 20, 2025

Mar 20, 2025

Skye Bioscience Reports Fourth Quarter And Full Year 2024 Financial Results And Provides Business Update - Marketscreener.com

Mar 20, 2025

Mar 20, 2025

Skye Bioscience, Inc. SEC 10-K Report - TradingView

Mar 20, 2025

Mar 20, 2025

Skye Bioscience Reports Fourth Quarter and Full Year 2024 Financial Results and Provides Business Update - GlobeNewswire

Mar 20, 2025

Mar 20, 2025

Skye's Obesity Drug Trial Hits Major Milestone with Strong Financial Backing - StockTitan

Mar 20, 2025

Mar 18, 2025

Skye Bioscience Inc expected to post a loss of 28 cents a shareEarnings Preview - TradingView

Mar 18, 2025

Mar 17, 2025

SKYE BIOSCIENCE Earnings Preview: Recent $SKYE Insider Trading, Hedge Fund Activity, and More - Nasdaq

Mar 17, 2025

Mar 14, 2025

Skye Bioscience to Announce 2024 Financial Results on March 20th, 2025 - The Manila Times

Mar 14, 2025

Mar 14, 2025

Skye Bioscience to Host Conference Call on March 20, 2025, to Discuss Q4 and Full-Year 2024 Financial Results - Nasdaq

Mar 14, 2025

Mar 14, 2025

Skye Bioscience Q4 Earnings: Obesity Treatment Pioneer Reveals 2024 Financial Performance - StockTitan

Mar 14, 2025

Mar 05, 2025

Brokerages Set Skye Bioscience, Inc. (NASDAQ:SKYE) Price Target at $18.67 - Defense World

Mar 05, 2025

Mar 05, 2025

Skye Bioscience, Inc. (NASDAQ:SKYE) Receives Consensus Recommendation of “Buy” from Brokerages - Defense World

Mar 05, 2025

Mar 04, 2025

Skye Bioscience, Inc. (NASDAQ:SKYE) Given Average Rating of "Buy" by Analysts - MarketBeat

Mar 04, 2025

Mar 04, 2025

Skye Bioscience (NASDAQ:SKYE) Trading Down 2%Should You Sell? - MarketBeat

Mar 04, 2025

Mar 04, 2025

Skye Bioscience (NASDAQ:SKYE) Coverage Initiated at William Blair - MarketBeat

Mar 04, 2025